No Data
Pacific Shuanglin Bio-pharmacy (000403.SZ): Some directors, supervisors, and core management personnel intend to increase their shareholding in the company by no less than 5 million yuan.
On December 27, Gelonghui reported that Pacific Shuanglin Bio-pharmacy (000403.SZ) announced that the company recently received a notice from some of its directors, supervisors, and core management personnel regarding their voluntary Shareholding plan. Based on confidence in the company's future development prospects and a high recognition of the company's value, to promote the healthy, stable, and long-term development of the company, safeguard the interests of shareholders, and enhance investor confidence, it is planned to increase the company's shares using self-owned funds through the Exchange trading system within six months from the date of this announcement (excluding periods where laws, regulations, and the business rules of the Shenzhen Stock Exchange do not permit shareholding increases). The total amount to be increased is.
Pacific Shuanglin Bio-pharmacy (SZSE:000403) Investors Are Sitting on a Loss of 27% If They Invested Three Years Ago
Pacific Shuanglin Bio-pharmacy (000403.SZ) will distribute 1.5 yuan for every 10 shares in the interim report, with the equity registration date set for December 16.
Pacific Shuanglin Bio-pharmacy (000403.SZ) announced that the company will implement the mid-term profit distribution for 2024, every 10 shares ...
Could The Market Be Wrong About Pacific Shuanglin Bio-pharmacy Co., LTD (SZSE:000403) Given Its Attractive Financial Prospects?
Pailin Biotech: Report for the third quarter of 2024
These 4 Measures Indicate That Pacific Shuanglin Bio-pharmacy (SZSE:000403) Is Using Debt Safely
There's Reason For Concern Over Pacific Shuanglin Bio-pharmacy Co., LTD's (SZSE:000403) Price
